CL2020001494A1 - Uso de una proteína no estructural de prv para proteger contra la inflamación del músculo esquelético y cardíaco. - Google Patents

Uso de una proteína no estructural de prv para proteger contra la inflamación del músculo esquelético y cardíaco.

Info

Publication number
CL2020001494A1
CL2020001494A1 CL2020001494A CL2020001494A CL2020001494A1 CL 2020001494 A1 CL2020001494 A1 CL 2020001494A1 CL 2020001494 A CL2020001494 A CL 2020001494A CL 2020001494 A CL2020001494 A CL 2020001494A CL 2020001494 A1 CL2020001494 A1 CL 2020001494A1
Authority
CL
Chile
Prior art keywords
prv
structural
muscle inflammation
protect against
cardiac muscle
Prior art date
Application number
CL2020001494A
Other languages
English (en)
Inventor
Stephane Villoing
Kjartan Hodneland
Petter Frost
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2020001494A1 publication Critical patent/CL2020001494A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/14—Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención está dirigida a un método de tratamiento en peces contra la inflamación del músculo esquelético y cardíaco causada por Piscine orthoreovirus (PRV), usando una proteína no estructural de PRV. La invención está dirigida además a vectores que comprenden una secuencia promotora y una secuencia codificante de ADN que codifica una proteína no estructural de PRV, y a composiciones de vacunas que comprenden estos vectores.
CL2020001494A 2017-12-06 2020-06-05 Uso de una proteína no estructural de prv para proteger contra la inflamación del músculo esquelético y cardíaco. CL2020001494A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17205626 2017-12-06

Publications (1)

Publication Number Publication Date
CL2020001494A1 true CL2020001494A1 (es) 2021-01-29

Family

ID=60629469

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001494A CL2020001494A1 (es) 2017-12-06 2020-06-05 Uso de una proteína no estructural de prv para proteger contra la inflamación del músculo esquelético y cardíaco.

Country Status (4)

Country Link
EP (1) EP3720486A1 (es)
CA (1) CA3083873A1 (es)
CL (1) CL2020001494A1 (es)
WO (1) WO2019110664A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO344967B1 (en) * 2019-01-30 2020-08-03 Patogen As Piscine Orthoreovirus Virulence Markers
CA3158539A1 (en) 2019-12-16 2021-06-24 Johanna Jacoba Elisabeth Bijlsma Inactivated piscine orthoreovirus vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
ES2247942B1 (es) 2004-08-27 2006-10-01 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) Construccion genica, vector y vacuna adn para la vacunacion de animales acuaticos.
CA2776534A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
CA2922621C (en) 2013-08-30 2023-05-23 Pharmaq As Method for propagating piscine orthoreovirus

Also Published As

Publication number Publication date
WO2019110664A1 (en) 2019-06-13
CA3083873A1 (en) 2019-06-13
EP3720486A1 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
CL2020000299A1 (es) Compuestos, composiciones y métodos.
MX2018012880A (es) Metodos para proporcionar arn de hebra sencilla.
CO2018012482A2 (es) Formulaciones de un inhibidor de lsd1
CL2018001056A1 (es) Vacuna contra el virus herpes simplex
CL2018001522A1 (es) Focalización de péptidos para dirigir virus adenoasociados (aavs)
UY38242A (es) Anticuerpos anti-cd33, anticuerpos bioespecíficos anti- cd33/anti-cd3 y usos de éstos
CO2019011250A2 (es) Administración de vectores del virus adenoasociado de microdistrofina específica del músculo para tratar la distrofia muscular
BR112018007017A2 (pt) polipeptídeos
CL2017001871A1 (es) Compuestos de piperidina urea 4-metilsulfonil-sustituidos para el tratamiento de miocardiopatía dilatada (mcd)
MD3718565T2 (ro) Vaccinuri împotriva virusului respirator
EA202091995A1 (ru) Композиции и способы лечения не связанного с возрастом нарушения слуха у субъекта-человека
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
CL2020001494A1 (es) Uso de una proteína no estructural de prv para proteger contra la inflamación del músculo esquelético y cardíaco.
UY38503A (es) Constructos de arni para inhibir la expresión de pnpla3 y métodos de uso de estos
BR112018000841A8 (pt) Agente estimulante de receptor 5-hidroxitriptamina1b para uso como um promotor de auto-renovação e/ou diferenciação de células satélites
BR112018014540A2 (pt) formulações/composições compreendendo inibidor de btk
BR112022005687A2 (pt) Vacinas contra o hbv e métodos para tratar o hbv
CO2021007916A2 (es) Ácido ribonucleico (arn) que codifica para una proteína
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
CO2022001977A2 (es) Anticuerpos anti-cd96 y sus métodos de uso
AR113618A1 (es) Péptidos antimicrobianos y métodos para usarlos
CL2021001254A1 (es) Vectores vegetales, composiciones y usos relacionados con los mismos
EA202091769A1 (ru) Вакцины против вируса гриппа и пути их применения
BR112016030294A2 (pt) Cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas